A collaborative research group has developed a novel therapeutic candidate that may improve the prognosis of severe cutaneous ...

A research team led by Prof. Ben Ko Chi-bun, Associate Professor of the PolyU Department of Applied Biology and Chemical Technology, has discovered the critical mechanism of action of tetrandrine, a ...

The Thai Cement Manufacturers Association (TCMA) presented its perspectives from the cement industry at the Thailand Climate Action Conference 2025 (TCAC 2025), highlighting that clear policies, laws, ...

Angioedema is deep swelling that occurs when fluid builds up under your skin or mucus membranes. It may affect your face, throat, gastrointestinal tract, or other parts of your body. Angioedema may ...

Please provide your email address to receive an email when new articles are posted on . In a Healio video exclusive, Edward V. Loftus Jr., MD, discusses the potential of tumor necrosis factor-like ...

Angiotensin converting enzyme (ACE) inhibitors, a type of blood pressure medication, are usually well tolerated, but one of their rare side effects is angioedema. Angiotensin converting enzyme (ACE) ...

The first day of NBA Summer League action culminated in a matchup between two top-5 picks in Utah: V.J. Edgecombe and the Philadelphia 76ers vs. Ace Bailey and the Utah Jazz. Only one of them posted a ...

Mouse microglia got a genetic tune-up. On 9 June in Nature Aging, researchers led by Warren G. Tourtellotte at Cedars-Sinai Medical Center in Los Angeles reported that expressing human ...

Angiotensin-converting enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs) are recommended widely as first-line treatments for hypertension in patients with diabetic or nondiabetic ...

A multicenter, randomized controlled trial of intrapleural drug-loaded vesicle perfusion combined with systemic therapy for malignant pleural effusion. This is an ASCO Meeting Abstract from the 2025 ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Circle Pharma, a clinical-stage biopharmaceutical company focused on developing cell-permeable macrocycle therapeutics, today announced a late-breaking ...

Circle Pharma, a clinical-stage biopharmaceutical company focused on developing cell-permeable macrocycle therapeutics, today announced a late-breaking poster presentation at the American Association ...